Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats

Diabetes

Volumn 52, Issue 5, 2003, Pages 1176-1181

  Cejvan, Kenan ^a   Coy, David H ^b   Efendic, Suad ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; INSULIN; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN 2 RECEPTOR; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; GLUCAGON RELEASE; HORMONAL REGULATION; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANIMALS; ARGININE; GENE EXPRESSION REGULATION; GLUCAGON; INSULIN; ISLETS OF LANGERHANS; KINETICS; MALE; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 0242432598     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.5.1176     Document Type: Article

References (37)

1. Alberti KG, Christensen NJ, Christensen SE, Hansen AP, Iversen J, Lundbaek K, Seyer-Hansen K, Orskov H: Inhibition of insulin secretion by somatostatin. Lancet 2:1299-1301, 1973
2. Efendic S, Luft R, Grill V: Effect of somatostatin on glucose induced insulin release in isolated perfused rat pancreas and isolated rat pancreatic islets. FEBS Lett 42:169-172, 1974
3. Gerich JE, Lorenzi M, Schneider V, Kwan CW, Karam JH, Guillemin R, Forsham PH: Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics. Diabetes 23:876-880, 1974
4. Koerker DJ, Ruch W, Chideckel E, Palmer J, Goodner CJ, Ensinck J, Gale CC: Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 184:482-484, 1974
5. Unger RH, Orci L: Possible roles of the pancreatic D-cell in the normal and diabetic states. Diabetes 26:241-244, 1977
6. Efendic S, Lins PE, Luft R, Uvnäs-Wallensten K, Szecowka J: Somatostatin: paracrine or endocrine substance? Front Hormone Res 7:41-51, 1980
7. Barden N, Lavoie M, Dupont A, Cote JP: Stimulation of glucagon release by addition of antisomatostatin serum to islets of Langerhans in vitro. Endocrinology 101:635-638, 1977
8. Itoh M, Mandarino L, Gerich JE: Antisomatostatin gama globulin augments secretion of both insulin and glucagon in vitro: evidence for a physiologic role for endogenous somatostatin in the regulation of pancreatic A- and B-cell function. Diabetes 29:693-696, 1980
9. Taborsky GJ Jr: Evidence for a paracrine role for pancreatic somatostatin in vivo. Am J Physiol 245:E598-E603, 1983
10. Kawai K, Ipp E, Orci L, Perrelet A, Unger RH: Circulating somatostatin acts on the islets of Langerhans by way of a somatostatin-poor compartment. Science 218:477-478, 1982
11. Unger RH, Orci L: Glucagon. In Ellenberg & Ridkin's Diabetes Mellitus. 5th ed. Porte D, Sherwin RS, Eds. Stamford, CT, Appleton & Lange, 1997, p. 115-139
12. Samols E, Stagner JI, Ewart RB, Marks V: The order of islet microvascular cellular perfusion is B-A-D in the perfused rat pancreas. J Clin Invest 82:350-353, 2001
13. Stagner JI, Samols E, Bonner-Weir S: β → α → δ pancreatic islet cellular perfusion in dogs. Diabetes 37:1715-1721, 1988
14. Stagner JI, Samols E: The vascular order of islet cellular perfusion in the human pancreas. Diabetes 41:93-97, 1992
15. Samols E, Stagner JI: Intra-islet cell-cell interactions and insulin secretion. Diabetes Reviews 4:207-223, 1996
16. Samols E, Stagner JI: Intraislet and islet acinar portal systems and their significance. In The Endocrine Pancreas. Samols E, Ed. New York, Raven Press, 1991, p. 93-124
17. Brunicardi FC, Kleinman R, Moldovan S, Nguyen TH, Watt PC, Walsh J, Gingerich R: Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas. Pancreas 23:302-308, 2001
18. Kleinman R, Gingerich R, Ohning G, Wong H, Olthoff K, Walsh J, Brunicardi FC: The influence of somatostatin on glucagon and pancreatic polypeptide secretion in the isolated perfused human pancreas. Int J Pancreatol 18:51-57, 1995
19. Patel YC, Srikant CB: Somatostatin receptors. Trends Endocrinol Metab 8:398-405, 1997
20. Csaba Z, Dournaud P: Cellular biology of somatostatin receptors. Neuropeptides 35:1-23, 2001
21. Hunyady B, Hipkin RW, Schonbrunn A, Mezey E: Immunohistochemical localization of somatostatin receptor SST2A in the rat pancreas. Endocrinology 138:2632-2635, 1997
22. Mitra SW, Mezey E, Hunyady B, Chamberlain L, Hayes E, Foor F, Wang Y, Schonbrunn A, Schaeffer JM: Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic β-cells. Endocrinology 140:3790-3796, 1999
23. Rossowski WJ, Coy DH: Potent inhibitory effects of a type four receptor-selective somatostatin analog on rat insulin release. Biochem Biophys Res Commun 197:366-371, 1993
24. Rossowski WJ, Coy DH: Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs. Biochem Biophys Res Commun 205:341-346, 1994
25. Hocart SJ, Jain R, Murphy WA, Taylor JE, Coy DH: Highly potent cyclic disulfide antagonists of somatostatin. J Med Chem 42:1863-1871, 1999
26. Herbert V, Lau KS, Gottlieb CW, Bleicher SJ: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965
27. Faloona GR, Unger RH: Radioimmunoassay technique. In Methods in Hormone Radioimmunoassay. Vol 1. Jaffe BN, Behrmann HE, Eds. New York, Academic Press, 1974, p. 324-326
28. Kanatsuna T, Lernmark Å, Rubenstein AH, Steiner DH: Block in insulin release from calcium-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement. Diabetes 30:231-234, 1981
29. Loubatieres AL, Mariani MM, Ribes G, De Malbosc H, Chapal J: Etude experimentale d'un nouveau sulfamide hypoglicemiant particulierement actif, le HB419 ou glibenclamide. Diabetologia 5:1-10, 1969
30. Östenson CG, Nylen A, Grill V, Gutniak M, Efendic S: Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect. Diabetologia 29:861-867, 1986
31. Reichlin S: Somatostatin. N Engl J Med 309:1495-1501, 1556-1563, 1983
32. Benali N, Ferjoux G, Puente E, Buscail L, Susini C: Somatostatin receptors. Digestion 62:27-32, 2000
33. Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, Patel SC, Patel YC: Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes 48:77-85, 1999
34. Rossowski WJ, Cheng BL, Jiang NY, Coy DH: Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedulin on gastric acid release using a new SRIF antagonist analogue. Br J Pharmacol 125:1081-1087, 1998
35. Kawakubo K, Coy DH, Walsh JH, Tache Y: Urethane-induced somatostatin mediated inhibition of gastric acid: reversal by the somatostatin 2 receptor antagonist, PRL-2903. Life Sci 65:115-120, 1999
36. Strowski MZ, Parmar RM, Blake AD, Schaeffer JM: Somatostatin inhibits insulin and glucagon secretion via two receptor subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 141:111-117, 2000
37. Tulipano G, Soldi D, Bagnasco M, Culler MD, Taylor JE, Cocchi D, Giustina A: Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454: effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. Endocrinology 143:1218-1224, 2002